Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
PER2 underexpression
Cancer:
Esophageal Squamous Cell Carcinoma
Drug:
cisplatin
(
DNA synthesis inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Biology (Basel)
Title:
PER2 Circadian Oscillation Sensitizes Esophageal Cancer Cells to Chemotherapy
Published date:
03/26/2021
Excerpt:
platin when PER2 expression is low enhances DNA damage and leads to a higher apoptosis rate.
DOI:
10.3390/biology10040266
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.